Mitral regurgitation following PASCAL mitral valve repair system: A single arm meta-analysis

Publication Date

2021

Journal Title

Indian Heart Journal

Abstract

Major consequences of untreated severe mitral regurgitation (MR) includes heart failure, ventricular remodeling and pulmonary hypertension leading to significant morbidity and mortality. MitraClip is the most widely used device for treatment of severe MR. To overcome some of the shortcomings of MitraClip, novel devices like PASCAL mitral valve repair system are developed. We performed a single arm meta-analysis for patients with severe mitral regurgitation (MR) undergoing PASCAL mitral valve repair system. The results showed that 93.8% patients had reduction in MR grade, with an average operative time of 88 min and an average increase of 86.33 m in 6-min walk test.

Volume Number

73

Issue Number

1

Pages

129 - 131

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Cardiology

PMID

33714399

DOI

10.1016/j.ihj.2020.12.003

This document is currently not available here.


Share

COinS